文献速递临床试验与 GCP

外部无创周围神经刺激治疗周围神经损伤后慢性神经病理性疼痛的随机、患者评估者盲法、假对照试验(EN-PENS试验):随机对照试验研究方案

A randomised, patient-assessor blinded, sham-controlled trial of external non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve injury (EN-PENS trial): study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2016-12-06

该研究为单中心、盲法、随机对照平行组优效性添加试验,采用1:1分配,计划纳入76例周围神经损伤后长期神经病理性疼痛患者,比较活性治疗与对照治疗的疗效。主要结局为治疗最后7天平均24小时疼痛强度(11点数字评分量表)。研究结果将用于评估EN-PENS的潜在疗效和成本效果。

要点

  • EN-PENS是一种笔状电极置于皮肤、患者可自行给药的周围神经电刺激。
  • 观察性研究提示EN-PENS可能缓解局部神经病理性疼痛,但尚无对照试验证据。
  • 本试验为单中心、盲法、随机对照平行组优效性添加试验,1:1分配,计划76例。

核心结论

  • 研究结果将用于评估EN-PENS在该人群中的潜在治疗疗效和成本效果。

研究设计与样本

  • 单中心、盲法、随机对照平行组优效性添加试验,1:1分配,计划纳入76例周围神经损伤后长期神经病理性疼痛患者。
  • 患者随机接受活性治疗或对照治疗,随后可选择治疗延长期或转换为替代治疗组。

主要发现

  • 观察性研究提示EN-PENS可能缓解局部神经病理性疼痛。
  • 目前尚无对照试验证据确认EN-PENS对长期神经病理性疼痛患者的疗效并可靠确定效应量。

关键数值与推荐

  • 主要结局为治疗最后7天平均24小时疼痛强度,采用11点(0-10)数字评分量表记录。

局限性

  • 目前尚无对照试验证据确认EN-PENS对长期神经病理性疼痛患者的疗效并可靠确定效应量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Eight percent of people in the UK are estimated to have persistent (chronic) neuropathic pain, and for many there is no effective treatment. Medications are the most common first-line treatment but often have limited benefit or adverse events. Surgical treatments, such as spinal cord stimulation, are then often considered. External non-invasive peripheral nerve stimulation (EN-PENS) is a form of electrical stimulation that involves placing a pen-shaped electrode onto the skin, which can be easily self-administered by patients. Observational studies suggest that EN-PENS may relieve pain for people with localised neuropathic pain; however, there is currently no evidence from controlled trials to confirm the efficacy and confidently determine the effect size for patients with longstanding neuropathic pain. METHODS: EN-PENS is a single-site, blinded, randomised controlled parallel-group superiority add-on trial with a 1:1 allocation ratio, designed to evaluate the efficacy of treatment versus control treatment in 76 patients with longstanding neuropathic pain following peripheral nerve injury. Patients with moderate to -severe neuropathic pain following peripheral nerve injury will be randomised to receive either the active or control treatment, followed by an optional treatment extension or treatment switch to the alternative treatment arm. The primary outcome is average 24-h pain intensity recorded on an 11-point (0-10) numerical rating scale, averaged over the last 7 days of treatment. DISCUSSION: Study results will be used to inform potential treatment efficacy and cost-effectiveness of EN-PENS for this population group. TRIAL REGISTRATION: ISRCTN53432663 . Registered on 7 July 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Johnson S, Goebel A, Richey R, et al. A randomised, patient-assessor blinded, sham-controlled trial of external non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve injury (EN-PENS trial): study protocol for a randomised controlled trial. Trials. 2016. PMID: 27919285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。